TARGIT-C(Consolidation) Prospective Phase IV Study of IORT in Patients With Small Breast Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

387

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Breast Cancer
Interventions
RADIATION

Intraoperative radiotherapy (IORT)

"The surgeon and radiation oncologist should choose the largest possible suitable applicator in order to ensure that the highest possible dose is delivered to the tumor bed tissue. A dose of 20 Gy at the surface of the applicator (in water) is prescribed by the radiation oncologist and delivered to the breast tissue. This takes approximately 20-50 minutes, depending on the size of the applicator.~To minimize radiation dependent side effects the skin-applicator surface distance should be more than 5 mm."

Trial Locations (4)

34125

Klinikum Kassel, Kassel

34298

Institut régional du Cancer de Montpellier, Montpellier

68167

Department of Radiotherapy University Hospital Mannheim, Mannheim

Unknown

IUCT, Toulouse, Toulouse

All Listed Sponsors
lead

Universitätsmedizin Mannheim

OTHER

NCT02290782 - TARGIT-C(Consolidation) Prospective Phase IV Study of IORT in Patients With Small Breast Cancer | Biotech Hunter | Biotech Hunter